Federal contract award
75N93022F00001
PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR HIV AND OTHER CANDIDATE AGENTS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | 75N93022D00005 |
| Set-aside | Not reported |
| Pricing type | COST NO FEE |
| Obligations | $8.4M |
| Current contract value | $8.4M |
| Potential contract value / ceiling | $8.4M |
| Start date | Dec 1, 2021 |
| Current end date | Aug 29, 2030 |
| Potential end date | Aug 29, 2030 |
| Latest award activity | Jun 30, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 7 of 7 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 30, 2026 | P00006 | $384.7K | EO 14398, CGMP MANUFACTURE, FILL-FINISH, RELEASE, ANALYTICAL AND STABILITY TESTING AND STABILITY PROGRAM OF A NANOPARTICLE BASED HIV ENVELOPE VACCINE |
| Apr 10, 2025 | P00005 | $3.4M | CGMP MANUFACTURE, FILL-FINISH, RELEASE, ANALYTICAL AND STABILITY TESTING AND STABILITY PROGRAM OF A NANOPARTICLE BASED HIV ENVELOPE VACCINE |
| May 13, 2024 | P00004 | $209.0K | CGMP MANUFACTURE, FILL-FINISH, RELEASE, ANALYTICAL AND STABILITY TESTING AND STABILITY PROGRAM OF A NANOPARTICLE BASED HIV ENVELOPE VACCINE |
| Dec 7, 2023 | P00003 | $471.6K | CGMP MANUFACTURE, FILL-FINISH, RELEASE, ANALYTICAL AND STABILITY TESTING AND STABILITY PROGRAM OF A NANOPARTICLE BASED HIV ENVELOPE VACCINE |
| Feb 27, 2023 | P00002 | $0 | CGMP MANUFACTURE, FILL-FINISH, RELEASE, ANALYTICAL AND STABILITY TESTING AND STABILITY PROGRAM OF A NANOPARTICLE BASED HIV ENVELOPE VACCINE |
| Aug 30, 2022 | P00001 | $4.0M | CGMP MANUFACTURE, FILL-FINISH, RELEASE, ANALYTICAL AND STABILITY TESTING AND STABILITY PROGRAM OF A NANOPARTICLE BASED HIV ENVELOPE VACCINE |
| Dec 1, 2021 | 0 | $2.5K | PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR HIV AND OTHER CANDIDATE AGENTS |
Estimated positioning window
Aug 29, 2029 – Feb 28, 2030
45/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 45/100. Available recorded signals: 40 points.
- Contract end 2030-08-29 (1397 days from calculation)
- +5 points
- 155 historical awards in this buyer and category group
- +15 points
- 7 recorded award transactions
- +10 points
- Latest award action: 2026-06-30
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.